United States · FDA National Drug Code directory
LEVOTHYROXINE SODIUM
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 31722-289_7c79df0b-836b-479b-a7a6-8e09b802a84e
- Product NDC
- 31722-289
- Form
- TABLET
- Composition / generic term
- levothyroxine sodium
- Labeler
- Camber Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230118
- Source listing expiry
- 20261231
Source-listed ingredients
- LEVOTHYROXINE SODIUM — .112 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (31722-289-01) · 31722-289-01
- 1000 TABLET in 1 BOTTLE (31722-289-10) · 31722-289-10
- 30 TABLET in 1 BOTTLE (31722-289-30) · 31722-289-30
- 90 TABLET in 1 BOTTLE (31722-289-90) · 31722-289-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →